Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 14 | 2017 | 173 | 2.250 |
Why?
|
| Monocytes | 7 | 2021 | 114 | 2.070 |
Why?
|
| Cholesterol | 12 | 2020 | 244 | 2.020 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2020 | 54 | 1.620 |
Why?
|
| Inflammation | 8 | 2020 | 513 | 1.610 |
Why?
|
| ATP-Binding Cassette Transporters | 6 | 2013 | 60 | 1.510 |
Why?
|
| Energy Metabolism | 2 | 2020 | 138 | 1.450 |
Why?
|
| Atherosclerosis | 9 | 2020 | 789 | 1.140 |
Why?
|
| Signal Transduction | 7 | 2020 | 743 | 1.110 |
Why?
|
| Mice | 28 | 2021 | 2382 | 1.000 |
Why?
|
| Lipoproteins, HDL | 7 | 2015 | 270 | 0.980 |
Why?
|
| Membrane Microdomains | 5 | 2015 | 25 | 0.900 |
Why?
|
| Succinates | 1 | 2020 | 4 | 0.830 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 8 | 0.820 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2020 | 14 | 0.820 |
Why?
|
| Animals | 31 | 2021 | 7531 | 0.790 |
Why?
|
| Apolipoprotein A-I | 7 | 2015 | 68 | 0.790 |
Why?
|
| Liver | 7 | 2017 | 472 | 0.780 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2017 | 31 | 0.730 |
Why?
|
| Toll-Like Receptors | 3 | 2015 | 23 | 0.720 |
Why?
|
| Mice, Inbred C57BL | 13 | 2017 | 707 | 0.720 |
Why?
|
| Autophagy | 2 | 2017 | 56 | 0.700 |
Why?
|
| Dietary Fats | 2 | 2017 | 119 | 0.680 |
Why?
|
| Receptors, LDL | 9 | 2020 | 63 | 0.650 |
Why?
|
| Mice, Knockout | 12 | 2020 | 434 | 0.640 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2010 | 16 | 0.630 |
Why?
|
| Lipopolysaccharides | 7 | 2020 | 100 | 0.620 |
Why?
|
| Myeloid Cells | 2 | 2014 | 41 | 0.620 |
Why?
|
| Aging | 3 | 2020 | 921 | 0.600 |
Why?
|
| Insulin Resistance | 4 | 2017 | 504 | 0.520 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 8 | 0.500 |
Why?
|
| Apolipoproteins | 5 | 2015 | 220 | 0.480 |
Why?
|
| Hematopoiesis | 1 | 2012 | 33 | 0.480 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 101 | 0.450 |
Why?
|
| Hepatocytes | 3 | 2017 | 77 | 0.430 |
Why?
|
| Carnitine | 2 | 2020 | 8 | 0.400 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 61 | 0.400 |
Why?
|
| Metabolome | 2 | 2020 | 29 | 0.390 |
Why?
|
| Amino Acids | 2 | 2020 | 39 | 0.390 |
Why?
|
| Cytokines | 5 | 2020 | 240 | 0.380 |
Why?
|
| Obesity | 3 | 2013 | 1087 | 0.360 |
Why?
|
| Cysteine | 2 | 2008 | 127 | 0.350 |
Why?
|
| Mitochondria | 2 | 2020 | 181 | 0.340 |
Why?
|
| Apolipoproteins E | 4 | 2013 | 104 | 0.290 |
Why?
|
| Sphingosine | 2 | 2015 | 14 | 0.280 |
Why?
|
| Lysophospholipids | 2 | 2015 | 25 | 0.280 |
Why?
|
| Cells, Cultured | 5 | 2015 | 791 | 0.270 |
Why?
|
| Plant Oils | 2 | 2015 | 14 | 0.270 |
Why?
|
| Macrophages, Peritoneal | 2 | 2014 | 18 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1096 | 0.270 |
Why?
|
| Interleukin-1beta | 3 | 2020 | 41 | 0.260 |
Why?
|
| Fatty Acids | 3 | 2020 | 89 | 0.260 |
Why?
|
| Chemokines | 2 | 2013 | 34 | 0.250 |
Why?
|
| Humans | 16 | 2020 | 29002 | 0.250 |
Why?
|
| Aortic Diseases | 2 | 2013 | 57 | 0.240 |
Why?
|
| Endothelium, Vascular | 3 | 2012 | 146 | 0.230 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 235 | 0.220 |
Why?
|
| NF-kappa B | 3 | 2010 | 74 | 0.220 |
Why?
|
| Enzyme Activation | 3 | 2017 | 133 | 0.220 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 20 | 0.220 |
Why?
|
| Glycolysis | 1 | 2020 | 23 | 0.210 |
Why?
|
| Gene Deletion | 4 | 2017 | 74 | 0.210 |
Why?
|
| Male | 12 | 2020 | 18424 | 0.210 |
Why?
|
| Lipids | 2 | 2020 | 225 | 0.210 |
Why?
|
| Ketones | 1 | 2020 | 5 | 0.210 |
Why?
|
| Diet, Atherogenic | 3 | 2015 | 61 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2021 | 172 | 0.210 |
Why?
|
| Caspase 1 | 2 | 2017 | 6 | 0.210 |
Why?
|
| NAD | 1 | 2019 | 21 | 0.200 |
Why?
|
| Transcription Factor RelB | 1 | 2019 | 21 | 0.200 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 32 | 0.200 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2009 | 14 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1035 | 0.200 |
Why?
|
| Immune Tolerance | 1 | 2019 | 64 | 0.200 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 11 | 0.190 |
Why?
|
| Nucleotides | 1 | 2019 | 14 | 0.190 |
Why?
|
| Aorta | 3 | 2015 | 114 | 0.190 |
Why?
|
| Antioxidants | 2 | 2010 | 113 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2017 | 19 | 0.170 |
Why?
|
| Algorithms | 1 | 2020 | 454 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 245 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2010 | 40 | 0.150 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2015 | 8 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 102 | 0.150 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 14 | 0.150 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 34 | 0.150 |
Why?
|
| Spleen | 2 | 2013 | 84 | 0.150 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 6 | 0.150 |
Why?
|
| Glycoproteins | 1 | 2015 | 34 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2015 | 98 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 67 | 0.140 |
Why?
|
| Fatty Acid Desaturases | 1 | 2015 | 48 | 0.140 |
Why?
|
| Proteomics | 1 | 2015 | 78 | 0.140 |
Why?
|
| Female | 7 | 2020 | 18719 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 115 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 70 | 0.140 |
Why?
|
| Fish Oils | 2 | 2015 | 35 | 0.140 |
Why?
|
| Lipocalins | 1 | 2013 | 6 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 6 | 0.130 |
Why?
|
| Mice, Obese | 1 | 2013 | 21 | 0.130 |
Why?
|
| Epididymis | 1 | 2013 | 9 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2015 | 283 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2015 | 267 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 174 | 0.130 |
Why?
|
| Vasculitis | 1 | 2013 | 24 | 0.130 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2003 | 3 | 0.130 |
Why?
|
| Diamide | 2 | 2003 | 3 | 0.130 |
Why?
|
| Apoptosis | 2 | 2012 | 373 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2013 | 85 | 0.130 |
Why?
|
| Chemotaxis | 1 | 2012 | 21 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 30 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2012 | 17 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 253 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2012 | 54 | 0.120 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 113 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 251 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2012 | 280 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 93 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2012 | 117 | 0.110 |
Why?
|
| Apolipoproteins A | 2 | 2008 | 26 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2012 | 179 | 0.110 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 6 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 978 | 0.110 |
Why?
|
| Cholesterol, VLDL | 3 | 2015 | 11 | 0.110 |
Why?
|
| Protein Transport | 1 | 2010 | 82 | 0.110 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2009 | 2 | 0.100 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2009 | 27 | 0.100 |
Why?
|
| Mutation | 3 | 2010 | 467 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 129 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2012 | 608 | 0.100 |
Why?
|
| Circular Dichroism | 2 | 2006 | 26 | 0.090 |
Why?
|
| beta-Cyclodextrins | 1 | 2008 | 3 | 0.090 |
Why?
|
| Endotoxemia | 1 | 2008 | 8 | 0.090 |
Why?
|
| Kringles | 1 | 2008 | 1 | 0.090 |
Why?
|
| Kinetics | 2 | 2006 | 188 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 62 | 0.090 |
Why?
|
| Time Factors | 3 | 2013 | 2046 | 0.090 |
Why?
|
| Lipid Peroxidation | 2 | 2005 | 36 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 30 | 0.090 |
Why?
|
| Biological Transport | 3 | 2013 | 64 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 37 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 91 | 0.090 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 72 | 0.080 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 14 | 0.080 |
Why?
|
| Models, Biological | 1 | 2008 | 372 | 0.080 |
Why?
|
| Lipoxygenase | 1 | 2005 | 1 | 0.080 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2005 | 5 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 34 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2005 | 43 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 42 | 0.070 |
Why?
|
| Plasmids | 1 | 2005 | 45 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 80 | 0.070 |
Why?
|
| Gene Expression | 2 | 2006 | 341 | 0.070 |
Why?
|
| Peptides | 1 | 2005 | 109 | 0.070 |
Why?
|
| Echium | 2 | 2015 | 10 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 200 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 77 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 666 | 0.060 |
Why?
|
| Cholesterol, LDL | 2 | 2014 | 175 | 0.060 |
Why?
|
| Cholesterol, Dietary | 2 | 2013 | 37 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2015 | 65 | 0.060 |
Why?
|
| Ceramides | 2 | 2012 | 8 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 590 | 0.060 |
Why?
|
| Neutrophils | 2 | 2013 | 105 | 0.060 |
Why?
|
| Fatty Liver | 2 | 2015 | 70 | 0.060 |
Why?
|
| Carbon | 1 | 2021 | 10 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 163 | 0.050 |
Why?
|
| Cell Wall | 1 | 2019 | 5 | 0.050 |
Why?
|
| Teichoic Acids | 1 | 2019 | 7 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 2 | 0.050 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2019 | 10 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 19 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2012 | 80 | 0.050 |
Why?
|
| Endotoxins | 1 | 2019 | 32 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2019 | 73 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 728 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 163 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2010 | 235 | 0.050 |
Why?
|
| Sepsis | 1 | 2019 | 138 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 21 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2015 | 9 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 19 | 0.040 |
Why?
|
| Cricetulus | 1 | 2015 | 19 | 0.040 |
Why?
|
| CHO Cells | 1 | 2015 | 28 | 0.040 |
Why?
|
| gamma-Linolenic Acid | 1 | 2015 | 8 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 23 | 0.040 |
Why?
|
| Cognition | 1 | 2019 | 536 | 0.040 |
Why?
|
| Ligands | 1 | 2015 | 81 | 0.040 |
Why?
|
| Proteome | 1 | 2015 | 27 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2015 | 48 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 78 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 266 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2015 | 102 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 339 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 35 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 42 | 0.030 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2013 | 38 | 0.030 |
Why?
|
| Bile | 1 | 2013 | 6 | 0.030 |
Why?
|
| Feces | 1 | 2013 | 28 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 349 | 0.030 |
Why?
|
| Foam Cells | 1 | 2013 | 8 | 0.030 |
Why?
|
| Animal Feed | 1 | 2013 | 14 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 44 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 292 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 221 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2003 | 4 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2012 | 6 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 181 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cell Line | 1 | 2013 | 434 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 838 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 92 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 220 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 115 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2012 | 140 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 72 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 14 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2003 | 544 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 1742 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2009 | 11 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 46 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 55 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 289 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 25 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 40 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 74 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2008 | 74 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 82 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 539 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 126 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 426 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 298 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 89 | 0.020 |
Why?
|
| Lung | 1 | 2008 | 237 | 0.020 |
Why?
|
| Protein Binding | 1 | 2006 | 198 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 232 | 0.020 |
Why?
|
| Sulfhydryl Reagents | 1 | 2003 | 5 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 8 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2003 | 12 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 17 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2002 | 15 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 134 | 0.020 |
Why?
|